Article
Mir‐1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53
26 Apr 2018
Abstract excerpt
BACKGROUND: Many chemotherapy regimens are used to treat breast cancer; however, breast cancer cells often develop drug resistance that usually leads to relapse and poor prognosis. MicroRNAs (miRNAs) are short non-coding RNA molecules that post-transcriptionally regulate gene expression and play crucial roles in diverse biological processes, such as development, differentiation, apoptosis, and proliferation. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
